ArticleScientific reports2026
Glial cell mapping in the camel cerebellar cortex: a histochemical and immunohistochemical study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Protective effect of dapagliflozin against phenytoin-induced cerebellar dysfunction and histological alterations in rats: the role of SIRT1/Nrf2/HO-1 pathway.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cerebellum is involved in numerous motor functions, the adaptation and execution of smooth complex voluntary and fine movements. Glial cells are essential for maintaining healthy neurons. Studying the camel cerebellum was neglected even in recent research even in the Middle East and Asia where camels are reared. Therefore, we investigated the glia in camel cerebellum employing histochemical and immunohistochemical staining using GFAP, Olig2, S-100 and Iba1 for astrocytes, oligodendrocytes, Bergmann glia and fibrous astrocytes, and microglia, respectively. The camel cerebellum was collected from ten clinically healthy mature camel’s (Camelus dromedarius) heads. GFAP immunoreactivity was not detected in the molecular layer, suggesting that this astrocytic population does not express GFAP. The distribution of astrocytes is heterogeneous between different layers and within the same layer. Bergmann glia was arranged into 4–6 rows in the Purkinje cell layer. Their processes extend radially through the molecular layer and reach the pial surface. Its mean density was 5126 cells/1 mm2. Oligodendrocytes were observed in the white matter and granular layer. The oligodendrocytes were either solitary or aligned in rows like beads along the nerve fascicles. Microglia were heterogeneous in both morphology and distribution in different layers and within the same layer. The white matter contains the highest mean density and they were elliptical and most processes run parallel to the nerve fibers. In the granular layer, elliptical- and oval bodies and their processes emerge from all over the cell bodies. The molecular layer contained oval microglia with short processes. Abundant Iba1 positive puncta distributed all over the molecular layer. The current study in camel is considered a step of comparative neuroglial biology across species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.